Avaliação neuropsicológica, marcadores inflamatórios e de neuroimagem no comprometimento cognitivo em indivíduos com doença renal crônica não dialítica
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Cognitive impairment (CI) is the decline of one or more cognitive domains.
There are pathophysiological factors common between chronic kidney disease (CKD)
and CI. The aim of this study was to compare the results of neuropsychological
assessment with findings of inflammatory markers and brain magnetic resonance
(MRI) in patients with CKD. This is a cross-sectional study in patients with CKD not
on dialysis in categories 1 to 5 in a secondary care clinic, from 2013 to 2014. The
project was approved by the Research Ethics Committee. Structured anamnesis,
application of clinical depression questionnaires, comprehensive neuropsychological
screening and Pfeffer's functionality questionnaire were performed.
Sociodemographic and clinical data were collected from medical records. Laboratory
data were collected including the dosage of IL-4, IL-6, IL-17, TNF- and us-CRP.
Brain MRI images were performed in a 1.5 Teslas high-field device, without the use
of paramagnetic contrast. The Fazekas scale was used to quantify white matter
lesions, the MTA scale to quantify hippocampal involvement, the ACG scale for
global cortical atrophy. A total of 111 patients were invited, eighty completed the
neuropsychological assessment and 56 patients underwent MRI and the other stages
of the study. Mean age was 56.3 ± 8.3 years, 55.4% men, 51.8% had altered MoCA.
Comparing those with changed MoCA vs. normal, it was observed that there was
less education (p = 0.04), greater use of diuretics (p = 0.04) and aspirin (p = 0.002);
in addition to higher levels of IL-6 (p = 0.02) and IL-17 (p = 0.05) among those with
altered MoCA. There was no correlation between MoCA and eGFR. MoCA correlated
with IL-6 (R -0.201, p = 0.04). There was a correlation between eGFR (IL-4 [R -0.467,
p = 0.005]; IL-6 [R -0.652, p < 0.001]; IL-17 [R -0.554, p = 0.001]), TNF- (R -0.684, p
< 0.001). In a linear regression model, the variables IL-17 and IL-6 were independent
predictors of lower MoCA values (CI -0.031 to -0.002, p = 0.002; CI -0.012 to -0.001,
p = 0.002). The other neuropsychological tests showed differences and associations
with sociodemographic, laboratory and imaging data, with no single pattern of
relationships having been determined. It was concluded that the prevalence of
changes in MoCA in this population was 51.8%, eGFR was correlated with
inflammation, MoCA was negatively correlated with IL-6. There was no association
between MRI findings and eGFR or inflammatory variables, and unlike IL-17 and IL6, eGFR was not a predictor of MoCA values.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

